Cargando…
Combinatory therapeutic approaches for common cold and SARS-CoV-2
Many countries in the world face the new challenge of having human coronavirus infection to manage commendably - the large affliction of human health. Together, each country has modern drugs and a variety of medicinal products developed from their traditional medical practitioners to treat a common...
Autores principales: | Anbalagan, Sankarappan, Arunprasanna, Vimalanathan, Dinakaran, Sundaram, Krishnan, Muthukalingan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837184/ http://dx.doi.org/10.1016/j.synres.2020.100069 |
Ejemplares similares
-
Census of cultivable bacterial community in common effluent treatment plant (CETP) of tannery discharge and computational scrutiny on their leading residents
por: Suganya, Thangaiyan, et al.
Publicado: (2013) -
Symptomic Mimicry Between SARS-CoV-2 and the Common Cold Complex
por: Tureček, Petr, et al.
Publicado: (2022) -
Is the “Common Cold” Our Greatest Ally in the Battle Against SARS-CoV-2?
por: Capoor, Manu N., et al.
Publicado: (2020) -
Engineering the common cold to be a live-attenuated SARS-CoV-2 vaccine
por: Kasman, Laura M.
Publicado: (2022) -
Adherence of SARS-CoV-2 Delta variant to a surgical mask and N95 respirators
por: Lorenzo-Leal, Ana C, et al.
Publicado: (2022)